RIGL Similar Chart Price Prediction
The price of RIGL is predicted to go up -3.29%, based on the high correlation periods with DVN. The similarity of these two price pattern on the periods is 96.47%.
RIGL
DVN
Down: -3.29%Similarity: 96.47%
RIGL Revenue Forecast
RIGL EPS Forecast
RIGL FAQs
What is RIGL revenue forecast for next quarter？
RIGL Analyst's Forecast
Kalpit Patel
B. Riley Securities
Hold
2024-12-10
Price Target
$27 → $20
Downside
-2.72%
B. Riley raised the firm's price target on Rigel Pharmaceuticals to $27 from $17 and keeps a Neutral rating on the shares. The shares rallied significant after earnings and the abstract update for R289 in lower-risk myelodysplastic syndrome, the analyst tells investors in a research note. The firm says that while it missed the opportunity to upgrade the stock after recognizing the early but encouraging data in the abstract, it upped the price target based on updated key opinion leader commentary.
Kalpit Patel
B. Riley Securities
Hold
2024-12-06
Price Target
$17 → $27
Upside
+6.09%
Allison Bratzel
Piper Sandler
Hold
2024-11-14
Price Target
$15 → $23
Downside
-16.24%
